MyOme Atlas™ FAQs
MyOme Atlas uses clinically integrated whole-genome sequencing to map comprehensive health risks and guide personalized care.
- What is MyOme Atlas™?
- What does the MyOme Atlas ™ test include?
- What is the MyOme Atlas Curated Screen™ test?
- Why do changes in a single gene matter?
- What is polygenic risk?
- What are some examples of conditions included in the MyOme Atlas Curated Screen™ test analysis?
- What affects how someone responds to medication?
- What is our Medication Response™ test?
- What is our Breast Cancer Integrated Risk test?
- What is our Coronary Artery Disease (CAD) Integrated Risk test?
- What impacts the risk for type 2 diabetes?
- How does the Type 2 Diabetes (T2D) Integrated Risk test help determine a person’s risk?
- How can knowing someone’s integrated risk score for type 2 diabetes help?
- Where can I find more information on type 2 diabetes genetics and risk?
- What is the integrated risk test for prostate cancer?
- Who is the Prostate Cancer Integrated Risk test for?
- How does the Prostate Cancer Integrated Risk test determine a person’s risk?
- How can knowing someone’s integrated risk score for prostate cancer help?
- Does a high integrated risk score mean someone will develop prostate cancer?
- What is the MyOme Atlas Curated Screen™ Test
- How is MyOme Atlas™ different from other genetic tests?
- What is our Type 2 Diabetes (T2D) test?
- How will risk be communicated on the MyOme Atlas™ Cancer report?
- How can someone use their MyOme Atlas™ results with their provider?
- Where can I find more information on prostate cancer and screening?
- What impacts the risk for prostate cancer?
- What are some example medications and genes in the Medication Response™ test?